Altratech has developed and patented a fundamentally novel process to detect and quantify DNA, RNA, Antibody, and Antigen molecular targets. The process replaces the need for time consuming ‘biological amplification’ required for optical read-outs, with almost instant ‘electronic signal amplification’ and a digital read-out. This will enable a new generation of portable diagnostic products that have the simplicity of lateral flow tests and the performance of a laboratory PCR test.
This novel digital diagnostic technology enables robust, straightforward and flexible molecular diagnostics in any environment.
About Altratech
Altratech is a team of twenty scientists and engineers, including nine PhDs, from cross-functional backgrounds of molecular biology, organic and synthetic chemistry, microfluidics, engineering and CMOS semiconductor technologies. With over 200 years of combined experience, our vision is to create portable high-performance diagnostics which will enable the next generation of decentralised connected healthcare and wellbeing.
At Altratech, our mission is to enable next generation molecular detection.
This exciting technology enables robust, straightforward and flexible molecular diagnostics in any environment.
Assay animation
In the News
Meet us at these upcoming events to see UbiHealth in action
11-13 Mar 2025: Tri-Con San Diego 13-15 Jan 2025: JP Morgan Healthcare Conference, San Francisco 11-12 Nov 2024: Medica Trade Fair, Dusseldorf 6 Nov 2024: BARDA Innovation Symposium, Washington DC
Altratech awarded up to €10.5M by EIC Accelerator
1 Oct 2024: Altratech awarded up to €10.5M grant+equity support by EIC Accelerator: .... EIC Accelerator 2024 full awardee list.... (Altratech's submission preparation assisted by MyEUConsulting SPRL).
Altratech contracted by BARDA for novel PNA Saliva SARS-CoV-2 project
This project has been funded in whole or in part with Federal funds from the US Department of Health and Human Services; Administration for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority, under Read More